In this 7-minute video Dr Hou, from Baylor College of Medicine, discusses his presentation in new therapeutic agents in development for treatment of IBD, from the September 26 virtual Advances in...
He discusses his session titled “The Microbiome and Fatty Liver Disease,” which he presented at Harvard’s Nonalcoholic Fatty Liver Disease (NAFLD): Mechanisms and Novel Therapeutics symposium.